高级检索
当前位置: 首页 > 详情页

Compliance of postoperative gastric cancer patients with oral nutritional supplementation and its influencing factors

| 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

机构: [1]The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei,
出处:
ISSN:

关键词: Gastric cancer surgical treatment nutritional supplement medication compliance

摘要:
To evaluate the compliance of postoperative gastric cancer patients with oral nutritional calcium supplementation and explore its influencing factors, in order to provide a reference for formulating relevant nursing interventions.A total of 269 postoperative patients with gastric cancer admitted to the third department of surgery of the Fourth Hospital of Hebei Medical University from February to July 2020 were selected retrospectively through convenient sampling. A general information questionnaire and the Chinese version of the modified medication adherence eight-item scale were used to conduct a cross-sectional survey, in order to evaluate the compliance of postoperative gastric cancer patients with oral nutritional supplementation.A total of 269 questionnaires were distributed in this study, and 228 valid questionnaires were finally recovered. The compliance score for oral nutritional calcium supplements in postoperative patients with gastric cancer was (6.43±0.21). The results of multiple linear regression analysis showed that the patients' education level, family monthly average income, postoperative time, medication belief and social support were factors influencing postoperative compliance with oral nutritional supplementation (P<0.05).The compliance of postoperative gastric cancer patients with oral nutritional calcium supplements is at a medium to low level. Patients' education level, family monthly average income, postoperative time, medication belief, and social support are the main influencing factors. It is necessary to formulate and implement relevant interventions to improve compliance.AJTR Copyright © 2023.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei,
共同第一作者:
通讯作者:
通讯机构: [1]The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, [*1]The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号